Clinical Trial Update: Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)

View source ↗

Summary

An ongoing clinical trial is investigating whether venetoclax plasma concentration relates to remission outcomes in adults with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venclexta (venetoclax)

Snippet

Sponsor: University Hospital, Caen | Conditions: Adult Acute Myeloid Leukemia | Status: RECRUITING